ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · Real-Time Price · USD
81.77
-0.97 (-1.17%)
At close: Dec 5, 2025, 4:00 PM EST
82.51
+0.74 (0.90%)
After-hours: Dec 5, 2025, 5:47 PM EST
ANI Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 1,709 | 1,079 | 1,052 | 656 | 771 | 348 | |
| Market Cap Growth | 47.13% | 2.58% | 60.42% | -14.98% | 121.46% | -52.48% | |
| Enterprise Value | 2,069 | 1,583 | 1,175 | 913 | 966 | 535 | |
| Last Close Price | 81.77 | 55.28 | 55.14 | 40.23 | 46.08 | 29.04 | |
| PE Ratio | 48.82 | - | 68.00 | - | - | - | |
| Forward PE | 10.54 | 10.72 | 14.04 | 14.79 | 12.86 | 7.15 | |
| PS Ratio | 1.95 | 1.76 | 2.16 | 2.07 | 3.57 | 1.67 | |
| PB Ratio | 3.38 | 2.52 | 2.30 | 1.94 | 2.15 | 1.78 | |
| P/TBV Ratio | - | - | 5.38 | 19.39 | 64.94 | 96.52 | |
| P/FCF Ratio | 10.98 | 22.59 | 9.56 | - | 1008.43 | 38.15 | |
| P/OCF Ratio | 10.01 | 16.86 | 8.85 | - | 232.23 | 22.82 | |
| PEG Ratio | - | 1.38 | 1.38 | 1.11 | 1.02 | - | |
| EV/Sales Ratio | 2.50 | 2.58 | 2.41 | 2.89 | 4.47 | 2.57 | |
| EV/EBITDA Ratio | 14.27 | 19.23 | 10.75 | 26.93 | 50.64 | 18.40 | |
| EV/EBIT Ratio | 38.56 | 108.31 | 23.73 | - | - | - | |
| EV/FCF Ratio | 13.29 | 33.14 | 10.67 | - | 1263.31 | 58.56 | |
| Debt / Equity Ratio | 1.25 | 1.47 | 0.62 | 0.85 | 0.80 | 1.02 | |
| Debt / EBITDA Ratio | 4.28 | 7.44 | 2.61 | 8.26 | 15.06 | 6.87 | |
| Debt / FCF Ratio | 4.06 | 13.20 | 2.60 | - | 375.65 | 21.88 | |
| Asset Turnover | 0.61 | 0.56 | 0.59 | 0.41 | 0.35 | 0.45 | |
| Inventory Turnover | 2.20 | 2.02 | 1.68 | 1.48 | 1.41 | 1.60 | |
| Quick Ratio | 1.94 | 1.93 | 2.63 | 2.15 | 2.61 | 1.32 | |
| Current Ratio | 2.58 | 2.73 | 3.57 | 3.46 | 3.68 | 2.17 | |
| Return on Equity (ROE) | 8.66% | -4.18% | 4.72% | -13.74% | -15.37% | -11.04% | |
| Return on Assets (ROA) | 2.49% | 0.83% | 3.72% | -2.10% | -2.86% | -2.12% | |
| Return on Capital (ROIC) | 3.05% | 1.01% | 4.52% | -2.53% | -3.38% | -2.43% | |
| Return on Capital Employed (ROCE) | 4.70% | 1.30% | 6.50% | -3.90% | -4.10% | -4.10% | |
| Earnings Yield | 2.00% | -1.72% | 1.79% | -7.30% | -5.52% | -6.47% | |
| FCF Yield | 9.11% | 4.43% | 10.46% | -6.11% | 0.10% | 2.62% | |
| Payout Ratio | - | - | 8.65% | - | - | - | |
| Buyback Yield / Dilution | -6.95% | -6.18% | -11.89% | -29.09% | -5.28% | 0.63% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.